Clinical Trial Update: Effects of Niaspan™ on High-density Lipoprotein (HDL) in Healthy Male Subjects (0000-069) [Phase 1]

View source ↗

Summary

A Phase 1 study assessing the effect of Niaspan on HDL cholesterol in healthy male subjects has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia

Drugs mentioned

• Niaspan (niacin (nicotinic acid))

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Dyslipidemia | Phase 1 | Status: COMPLETED